Cafepharma Today

June 5 2025 - GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
GLP-1 drugs may be linked to elevated risk of serious eye disease, study finds
Bispecific cancer drugs, data caveats and funding alarms: 3 takeaways from ASCO
FDA’s Elsa AI is here, and the industry has questions
Merck gains U.S. patent office support in Keytruda dispute
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Another Twist in the Chronicles of Avandia! .
WSJ
Saturday, August 14, 2010 - 12:41pm
tags:
Avandia, GSK, diabetes
Merck: Dividend Dynamo or Disaster?
Motley Fool
Saturday, August 14, 2010 - 12:39pm
tags:
Merck, investors
Vaccine sales up 16 pct in 2009, still growing
Yahoo/AP
Saturday, August 14, 2010 - 12:36pm
tags:
vaccines, Merck, GSK, Pfizer, Novartis, Sanofi
Drug Industry Weighs Allegiance .
WSJ
Saturday, August 14, 2010 - 12:29pm
tags:
GlaxoSmithKline Tells Execs to Leave Nonprofit Selling Resveratrol Supplements .
WSJ
Saturday, August 14, 2010 - 12:28pm
tags:
reserveratrol, GSK, Sirtuin
Kendall Law Group Investigates Trubion Pharmaceuticals, Inc. Acquisition for Shareholders
Yahoo/BusinessWire
Saturday, August 14, 2010 - 12:24pm
tags:
Trubion, legal, M&A
Nasdaq Grants Repros Extension until October 31, 2010 to Meet Minimum Bid Price Listing Requirement
Yahoo/BusinessWire
Saturday, August 14, 2010 - 12:22pm
tags:
Repros Therapeutics
BioSante Pharmaceuticals: Warming Up or Cooling Off?
Motley Fool
Saturday, August 14, 2010 - 12:20pm
tags:
BioSante, investors
Cell Second Quarter Net Loss Widens
Yahoo/Zacks
Saturday, August 14, 2010 - 12:19pm
tags:
Cell Therapeutics, earnings, investors
Trubion shares skyrocket after Emergent deal announced
bizjournals
Saturday, August 14, 2010 - 12:16pm
tags:
Trubion, Emergent BioSolutions, arthritis, lupus, non-Hodgkin's lymphoma, leukemia
PDL tumbles on Roche patent dispute
Marketwatch
Friday, August 13, 2010 - 12:03pm
tags:
PDL Biopharma, Roche, patents, Europe, Avastin, Herceptin, Lucentis, Xolair
Is pharma marketing ready for its digital close-up?
Fierce Pharma
Friday, August 13, 2010 - 11:56am
tags:
pharma marketing, e-marketing
Marginal Performance at Alcon
Motley Fool
Friday, August 13, 2010 - 11:52am
tags:
JNJ, Merck, Alcon, Eli Lilly, Ista
Is Gilead Sciences Growing Foolishly?
Motley Fool
Friday, August 13, 2010 - 9:22am
tags:
Gilead Sciences, Merck, Genzyme
Compugen Goes the Extra Mile in Drug Discovery
Seeking Alpha
Friday, August 13, 2010 - 9:20am
tags:
drug discovery, CompuGen
Emergent buys Trubion for up to $135M
Fierce Biotech
Friday, August 13, 2010 - 9:20am
tags:
Emergent BioSolutions, Trubion, M&A
Genzyme’s Takeover Defense Against Sanofi Is Its Own Incompetence
BNET Pharma
Friday, August 13, 2010 - 9:17am
tags:
Genzyme, M&A, Sanofi
Sanofi-Aventis Forges Research Alliance to Expand Pipeline Sources
Seeking Alpha
Friday, August 13, 2010 - 9:15am
tags:
Sanofi, Scripps Health, partnerships, R&D
The FDA Probes Glaxo Over Avandia Disclosures
Pharmalot
Friday, August 13, 2010 - 7:41am
tags:
FDA, Avandia, GSK, diabetes
Simcere 2Q earnings climb nearly 4 pct to $5.7M
Yahoo/AP
Friday, August 13, 2010 - 7:38am
tags:
earnings, Simcere

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.